Clin2
NCT07421375Possibly a fitNot yet recruiting

Study of a new medicine for healthy volunteers

Essential Hypertension

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests a new medicine in healthy people to see how it is absorbed and broken down by the body, and to make sure it is safe. If you join, you will take the medicine under fasting conditions and have regular blood tests.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
58 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You must be a healthy adult aged 19 or older (this is typical for early-phase trials).
  • Your body mass index (BMI) must be between 18.0 and 30.0 kg/m².
  • You must agree to use highly effective contraception (except hormonal methods) from signing consent until 14 days after the last dose, and not donate sperm or eggs.
  • You must not have taken certain medications (like barbiturates) within 30 days, or any prescription, over-the-counter, herbal, or dietary supplements within 10 days before the first dose.
  • You must not have had stomach or intestinal surgery (except simple appendectomy or hernia repair) or have diseases that affect drug absorption.
  • You must not have participated in another clinical trial with an investigational product within 6 months before the first dose.
  • You must be able to avoid foods containing grapefruit from 48 hours before the first dose until the last blood sample.
  • You must not be pregnant, planning pregnancy, or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07421401Not yet recruiting· Phase 1
Testing a new drug in healthy adults

This study checks how a new drug (BR1015-A) moves through your body and whether it is safe. Healthy volunteers take the drug under fasting conditions (no food), and doctors watch for any side effects.

NCT07421388Not yet recruiting· Phase 1
Study of BR1015 medicines under fed conditions

This study tests a new medicine called BR1015 to see how it is absorbed and broken down in the body when taken with food. The results may help doctors learn the best way to give this medicine in the future.

NCT07421414Not yet recruiting· Phase 1
Study of a new combination treatment taken after a meal

This trial tests a new medicine given as two separate products taken together after a meal. It is for healthy volunteers to see how the medicine is processed by the body and if it is safe.

NCT07373613Not yet recruiting· Phase 2
Blood pressure study for people with high blood pressure

This study tests five new medicines to see if they can lower blood pressure in people with mild to moderate essential hypertension. It may help you if your blood pressure is not well controlled and you are willing to take the study medicine for a period of time.

Soeul
NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT07609875Not yet recruiting· Phase 1
Testing a new blood pressure medicine in healthy and mildly hypertensive people

This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.

Hear when a new Essential Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.